Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertensionheart failure and percutenous coronary interventions (PCI).

News

 

November 15, 2011 – Results of the PARTNER Cohort A QOL study demonstrate that transcatheter aortic valve replacement ...

Home November 15, 2011
Home
News

November 15, 2011 – Abbott announced positive long-term data from the two-stage ABSORB trial, which is evaluating the ...

Home November 15, 2011
Home
News

November 15, 2011 — Results of ADAPT-DES (Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents) were ...

Home November 15, 2011
Home
News

November 15, 2011 Results from the PROFI study indicate that the use of a proximal balloon occlusion in carotid artery ...

Home November 15, 2011
Home
News

November 15, 2011 — Researchers have found polymer-free amphilimus-eluting stents in de novo coronary artery lesions ...

Home November 15, 2011
Home
News

November 15, 2011 — A randomized clinical trial examining angioplasty approaches in patients with ST elevation acute ...

Home November 15, 2011
Home
News

November 15, 2011 — The ADVISE clinical trial concluded that a new measure of stenosis severity — instantaneous wave ...

Home November 15, 2011
Home
News

November 15, 2011 — A new clinical trial is testing the efficacy of rotational atherectomy (or rotablation, a process of ...

Home November 15, 2011
Home
News

November 15, 2011 — A clinical trial has shown a drug-eluting stent (DES) with a bioabsorbable polymer has comparable ...

Home November 15, 2011
Home
News

November 14, 2011 — A clinical trial of patients with restenosis in drug-eluting stents (DES) in native coronary ...

Home November 14, 2011
Home
News

November 14, 2011 – Boston Scientific welcomed positive outcomes from the COBRA clinical trial, which evaluated post ...

Home November 14, 2011
Home
News

November 14, 2011 – Medrad Inc. announced that five-year data from the THUNDER trial [1] demonstrated a 59 percent ...

Home November 14, 2011
Home
News

November 14, 2011 – OrbusNeich announced the introduction of the Combo dual therapy stent during a breakfast symposium ...

Home November 14, 2011
Home
News

November 14, 2011 – The TWENTE clinical trial, which compared Resolute versus Xience V drug-eluting stents in a real ...

Home November 14, 2011
Home
News

November 11, 2011 – Boston Scientific reported results from the EVOLVE first human use trial demonstrating the non ...

Home November 11, 2011
Home
Subscribe Now